Urologic disorders include both urological malignancies and benign urologic diseases, which are common and affects all age groups. In the context of clinical epidemiology, epidemiology of urologic diseases is concerned with prognosis and outcome of treatment among patients with urologic disorders.
Of special interest to us at Department of Clinical Epidemiology is the long-term consequences of not only malignant but also benign urinary tract diseases. Our research in urologic malignancies focuses on prognostic factors for prostate cancer, kidney cancer, and bladder cancer including the role of comorbidities, and the progression from carcinoma in-situ lesions to fulminant cancer. The uro-oncologic research at DCE is closely interwoven with our cancer epidemiology research.
Benign urological lower tract diseases are common and affect all age groups. The health care system tends to direct resources towards cancer diagnostics and treatment, which leaves limited resources for benign urologic disorders. By focusing on long-term consequences of benign urinary tract disorders such as congenital malformations of the urinary tract, vesicoureteral reflux, and benign prostatic hyperplasia, our research aims to strengthen the level of scientific evidence within clinical urology, thus providing knowledge needed to prioritize resources and guide clinical decision-making.